In the present study, the spectroscopic characterization of novel pyrazoline scaffold was studied. Title compounds were synthesized by microwave and conventional heating method and are characterized by FT-IR, H-1 NMR, C-13 NMR and analytical data. The single crystal X-ray diffraction method was used to determine the three-dimensional structures of the compounds 4a and 4c. From the X-ray analysis, it was observed that two compounds 4a and 4c crystallizes in triclinic crystal system with P-1 space group respectively. The compounds 4a and 4c crystallized with cell parameters a = 10.3700 (7) angstrom, b = 10.91607 (7) angstrom, c = 12.7822 (7) angstrom, alpha = 107.280 (5)degrees, beta = 98.438 (5)degrees, gamma = 116.105 (7)degrees, V = 1173.94 (17) angstrom(3), Z = 2 and a= 10.2990 (7) angstrom, b = 10.9915 (8) angstrom, c = 12.5985 (7) angstrom, alpha = 104.725 (5)degrees, beta = 99.074 (5)degrees, gamma = 116.249 (7)degrees, V = 1175.60 (17) angstrom(3), Z= 2. In the crystal structures, 4a and 4c pyrazoline ring (Cg3: N3-N4/C11-C13) adopts envelope conformation with respect to asymmetric carbon. The intercontacts present in the molecules are quantified using Hirshfeld surface computational method. The major intercontacts present in these molecules are H center dot center dot center dot H (50.4%), C center dot center dot center dot H (16.8%) (4a) and H center dot center dot center dot H (44.6%), Cl center dot center dot center dot H (17.1%) (4c) respectively. Synthesized compounds were screened for in-silico docking analysis with the Human androgen receptor. Also, the in-vitro antibacterial, antioxidant activities were performed. The UV-visible study indicates the presence of pi - pi* transition in the title compounds. (C) 2019 Published by Elsevier B.V.